Interview 4 - Antimalarials in rheumatology with Dr. Sasha Bernatsky

Поделиться
HTML-код
  • Опубликовано: 2 окт 2024
  • Dr. Bernatsky, rheumatologist, James McGill professor, and senior scientist in the Centre for Health Outcomes Research and Division of Clinical Epidemiology at the Research Institute of the MUHC, discusses the crucial role antimalarials such as hydroxychloroquine play in the management of inflammatory arthritis, like rheumatoid arthritis, offering a favorable balance between efficacy and safety. The benefits of these medications include slowing down disease progression, reducing joint pain and protecting against organ damage, especially in systemic lupus erythematosus.
    Resources:
    • Smoking status, antimalarial use heavily influence cancer risk in SLE -www.healio.com...
    • Arthritis Consumer Experts’ About Lupus page - bit.ly/ACEabou...
    ‪@JointHealth‬
    ‪@mcgillu‬
    ‪@ArthritisResearchCanada‬
    ‪@lupuscanada9793‬
    ‪@ArthritisSociety‬

Комментарии •